Fasting plasma glucose in screening for diabetes in the Taiwanese population

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1856-1860

  Chang, Chih Jen ^a,c   Wu, Jin Shang ^a   Lu, Feng Hwa ^a,b   Lee, Hwei Ling ^a   Yang, Y I Ching ^a   Wen, Mlin Jye ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; TAIWAN;

EID: 0031782685     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1856     Document Type: Article

References (33)

1. Department of Health: Public Health in Taiwan Area, Republic of China. Taipei, Department of Health, Executive Yuan, 1995
2. Modan M, Halkin H, Karasik A, Lusky A: Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 119:431-444, 1984
3. U.S. Department of Health and Human Services/Public Health Service (DHHS/PHS): Adults/older adults screening: plasma glucose. In Clinician's Handbook of Preventive Services: Put Prevention Into Practice. DHHS/PHS Ed. Washington D.C., U.S. Government Printing Office, 1994, p. 201-204
4. British Diabetic Association: Population screening for diabetes mellitus, Diabet Med 10:777-781, 1993
5. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
6. Knowler WC: Screening for NIDDM: opportunities for detection, treatment, and prevention. Diabetes Care 17:445-450, 1994
7. Forrest RD, Jackson CA, Yudkin JS: The abbreviated glucose tolerance test in screening for diabetes: the Islington Diabetes Survey. Diabet Med 5:557-561, 1988
8. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin, and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study Diabetologia 39:298-305, 1996
9. Stern MP, Valdez RA, Haffner SM, Mitchell BD, Hazuda HP: Stability over time of modern diagnostic criteria for type II diabetes. Diabetes Care 16:978-983, 1993
10. Olefsky JM, Reaven GM: Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 23:449-453, 1974
11. Kosaka K, Mizuno Y, Kuzuya T: Reproducibility of the oral glucose tolerance test and the rice-meal test in mild diabetics. Diabetes 15:901-904, 1966
12. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE: Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests, Diabetes 27:715-725, 1978
13. Stolk RR Orchard TJ, Grobbee DE: Why use the oral glucose tolerance test? Diabetes Care 18:1045-1049, 1995
14. Davidson MB, Peters AL, Schriger DL: An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care 18:1065-1071, 1995
15. Rushforth NB, Miller M, Bennett PH: Fasting and two-hour post-load glucose levels for the diagnosis of diabetes: the relationship between glucose levels and complications of diabetes in the Pima Indians. Diabetologia 16:373-379, 1979
16. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects. Diabetologia 36:1175-1184, 1993
17. Stolk RP, Vingerling JR, de Jong FT, Dielemans I, Hofman A, Lamberts SWJ, Pols HA, Grobbee DE: Retinopathy, glucose, and insulin in an elderly population: the Rotterdam Study. Diabetes 44:11-15, 1995
18. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC: Which test for diagnosing diabetes? Diabetes Care 18:1042-1044, 1995
19. Rose G, Keen H, Jarrett J: Epidemiologic methods in diabetic macrovascular disease. Diabetes Care 2:91-97, 1979
20. Taylor R, Zimmet P: Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus. Diabetes Care 4:556-558, 1981
21. Finch CF, Zimmet PZ, Alberti KG: Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 7:603-610, 1990
22. Simon D, Coignet MC, Thibult N, Senan C, Eschwege E: Comparison of glycosylated hemoglobin and fasting plasma glucose with two-hour post-load plasma glucose in the detection of diabetes mellitus. Am J Epidemiol 122:589-593, 1985
23. Wiener K: Fasting plasma glucose as a diagnostic indicator of diabetes mellitus. Clin Chim Acta 238:199-208, 1995
24. Cockram CS, Lau JT, Chan AY, Woo J, Swaminathan R: Assessment of glucose tolerance test criteria for diagnosis of diabetes in Chinese subjects. Diabetes Care 15:988-990, 1992
25. Ramachandran A, Snehalatha C, Vijay V, Viswanathan M: Fasting plasma glucose in the diagnosis of diabetes mellitus: a study from Southern India. Diabet Med 10:811-813, 1993
26. Clements JR French LR, Boen JR, Sprafka JM, Hedlund B, Goetz FC: A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study Acta Diabctol 31:187-192, 1994
27. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1985 (Tech. Rep. Sen, no. 727), p. 9-12
28. American Diabetes Association: The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (Committee Report). Diabetes Care 20:1183-1197, 1997
29. 1clevels for diagnosing diabetes: diagnostic criteria and performance revised. Diabetes Care 20:785-791, 1997
30. Orchard TJ: From diagnosis and classification to complications and therapy: DCCT, Part II, Diabetes Control and Complications Trial. Diabetes Care 17:326-338, 1994
31. Modan M, Harris MI: Fasting plasma glucose in screening for NIDDM in the U.S. and Israel. Diabetes Care 17:436-439, 1994
32. Harris M: Public health impact of diabetes. In Advances in Diabetes Epidemiology. Eschwege E, Ed. Amsterdam, Elsevier Biomedical, p. 17-21, 1982
33. McCane DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and twohour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994